MDI/TDI & Polyols

US Imposes Anti-Dumping Duties on Chinese MDI Following ITC Injury Determination

US imposes anti-dumping duties on Chinese MDI after ITC injury determination—key implications for exporters, buyers & compliance teams. Act now.
Time : May 29, 2026

On May 1, 2026, the U.S. International Trade Commission (ITC) issued an affirmative final determination that imports of methylene diphenyl diisocyanate (MDI) from China are causing material injury to the domestic U.S. industry. This decision triggers the imminent issuance of an anti-dumping duty order by the U.S. Department of Commerce—directly affecting market access and pricing competitiveness for Chinese MDI exporters.

Key Facts of the ITC Final Determination

On May 1, 2026, the U.S. International Trade Commission voted unanimously to affirm that imported MDI from China is causing material injury to the U.S. domestic industry. Based on this finding, the U.S. Department of Commerce will issue an anti-dumping duty order. The affected Harmonized Tariff Schedule (HTS) numbers are 2929.10.8010 and 3909.31.0000. This action applies specifically to MDI products originating in China and establishes a formal trade remedy framework under U.S. law.

Impact Across the Supply Chain

Exporters and Direct Trading Firms

Chinese MDI producers and exporters face immediate tariff exposure upon entry into the U.S. market. The anti-dumping duties will increase landed costs, potentially eroding price competitiveness and prompting reevaluation of U.S.-bound shipment volumes, pricing strategies, and contract terms—including Incoterms and liability clauses.

Raw Material Procurement Entities

Downstream buyers sourcing MDI for polyurethane formulation—especially those with long-term supply agreements or just-in-time inventory models—may encounter cost volatility and delivery delays. Procurement teams must reassess supplier diversification, contractual force majeure provisions, and alternative sourcing options, including regional alternatives or vertically integrated suppliers.

Manufacturers and Formulators

U.S.-based and multinational manufacturers using MDI as a core raw material face upward pressure on input costs. This may accelerate internal reviews of formulation adjustments, process efficiency gains, or substitution feasibility—particularly where technical specifications permit alternatives such as TDI or HDI under specific application constraints.

Supply Chain Service Providers

Cargo forwarders, customs brokers, and trade compliance consultants will see increased demand for tariff classification verification, origin documentation support, and anti-dumping duty calculation services. Ensuring accurate HTS coding (especially distinguishing between 2929.10.8010 and 3909.31.0000) and maintaining robust records for potential administrative reviews becomes operationally critical.

Strategic Priorities for Affected Enterprises

Verify HTS Classification and Origin Documentation

Companies must confirm precise tariff line alignment for their MDI-related goods—particularly whether shipments fall under chemical (2929.10.8010) or polymer-based (3909.31.0000) classifications. Supporting documentation, including certificates of origin and production records, must meet U.S. Customs and Border Protection evidentiary standards.

Assess Export Compliance Readiness

Exporters should initiate internal audits of pricing methodologies, cost structures, and transfer pricing policies—key inputs for potential U.S. Department of Commerce administrative reviews. Preparing responsive submissions in advance can reduce procedural risk during investigations.

Evaluate Market Access Alternatives

Firms should explore indirect routes—including third-country blending, toll manufacturing, or regional warehousing—while ensuring strict adherence to U.S. rules of origin and anti-circumvention enforcement priorities. Any such strategy requires legal review to avoid inadvertent violations.

Strengthen Technical and Regulatory Documentation

For downstream users, maintaining comprehensive technical dossiers—including safety data sheets (SDS), polymerization test reports, and regulatory compliance statements—supports both procurement due diligence and potential defense in future trade remedy proceedings.

Industry Perspective: Beyond Tariffs to Structural Adjustment

Analysis shows this determination reflects a broader tightening of U.S. trade enforcement around high-value chemical intermediates—not merely as a pricing intervention, but as a strategic signal regarding supply chain resilience and domestic industrial capacity. From an industry perspective, the case underscores how anti-dumping measures increasingly intersect with chemical regulatory frameworks (e.g., TSCA compliance) and sustainability reporting expectations. What deserves closer attention is the growing linkage between trade remedy outcomes and ESG-aligned procurement criteria among major U.S. buyers—where tariff exposure may compound reputational or contractual risks beyond pure cost impact.

Looking Ahead: Uncertainties and Adaptive Pathways

This ruling marks a definitive shift in the U.S. trade posture toward key chemical intermediates—but not a closed chapter. The final duty rates, scope of product coverage, and implementation timeline remain subject to formal publication in the Federal Register and possible judicial review. For stakeholders, sustained attention is warranted on upcoming administrative reviews, potential exclusions petitions, and evolving guidance from U.S. Customs on enforcement thresholds and recordkeeping expectations.

Source Attribution and Verification Notice

This article was generated based solely on the user-provided title, event date (May 1, 2026), and summary description. Specific official source links were not provided in the input and should be verified continuously. Stakeholders are advised to monitor updates from the U.S. International Trade Commission (ITC), the U.S. Department of Commerce’s Enforcement and Compliance unit, and the Federal Register for binding regulatory text, notice of opportunity to comment, and procedural deadlines. Ongoing observation is recommended for related developments—including potential parallel investigations, industry coalition responses, and shifts in procurement policy among major U.S. end-users.

Recommended News